A multivariable prediction model combining 18F-PSMA PET/CT and mpMRI for clinically significant prostate cancer: development and validation - Top-Institutions - MDSpire

A multivariable prediction model combining 18F-PSMA PET/CT and mpMRI for clinically significant prostate cancer: development and validation

  • By

  • Chaojian Yu

  • Zihou Zhao

  • Peidong Tian

  • Jingcheng Zhou

  • Lin Cai

  • Jianhui Qiu

  • Kan Gong

  • May 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Urology

  • #2

    The First Affiliated Hospital of Guangzhou Medical University
    The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

    Key Differentiators

    • Urology

  • #3

    Xiangya Hospital
    Xiangya Hospital

    Changsha, China

    Key Differentiators

    • Urology

  • #4

    Qilu Hospital
    Qilu Hospital

    Jinan, China

    Key Differentiators

    • Urology

  • #5

    Leeds Teaching Hospitals NHS Trust
    Leeds Teaching Hospitals NHS Trust

    Leeds, UK

    Key Differentiators

    • Urology

Original Source(s)

A multivariable prediction model combining 18F-PSMA PET/CT and mpMRI for clinically significant prostate cancer: development and validation

  • by Chaojian Yu, Zihou Zhao, Peidong Tian, Jingcheng Zhou, Lin Cai, Jianhui Qiu, Kan Gong

  • May 18, 2026

Related Content

Real-world healthcare resource use and costs associated with the management of locally advanced head and neck cancer in Portugal – TRACE2 study

Lenvatinib induces ferroptosis-related changes in osteosarcoma cells involving the p-STAT3/p53/xCT axis

From AI-based image analysis to surgical decision support in prostate cancer: interdisciplinary application of the international radiomics platform